Copertina

Nuclear factors that govern endotoxin tolerance in the myeloid lineage.

Fuente: Zenodo

Salvato in:

Dettagli Bibliografici
Autore principale:	Mamoor, Shahan
Natura:	Recurso digital
Pubblicazione:	Zenodo 2025
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Gasdermin activation during lineage specification in the human embryo.
di: Mamoor, Shahan
Pubblicazione: (2026)

Androgen signaling has functions in lineage commitment in the human embryo.
di: Mamoor, Shahan
Pubblicazione: (2026)

The mIR-302 cluster is silenced upon differentiation to the mechanosensory lineage.
di: Mamoor, Shahan
Pubblicazione: (2026)

Casz1 mobilization during TE lineage specification from the pluripotent state in embryonic stem cells.
di: Mamoor, Shahan
Pubblicazione: (2026)

A retrotransposon-like gene, RTL5, is modulated during differentiation of embryonic stem cells to the trophectoderm lineage.
di: Mamoor, Shahan
Pubblicazione: (2026)

Haglr, a HOXD antisense growth-associated long non-coding RNA with functions in lineage commitment in the human embryo.
di: Mamoor, Shahan
Pubblicazione: (2026)

Control of TOX transcription factors by the Hippo signaling pathway.
di: Mamoor, Shahan
Pubblicazione: (2025)

NLR family genes influence homeobox transcription factor expression.
di: Mamoor, Shahan
Pubblicazione: (2025)

Glucocorticoid resistance features changes in general transcription factor (GTF) expression.
di: Mamoor, Shahan
Pubblicazione: (2025)

The homeobox transcription factor TCF7 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

The homeobox transcription factor MEOX1 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

Kinase activation during small molecule inhibition of the receptors for the vascular endothelial growth factors VEGFR1 and VEGFR2.
di: Mamoor, Shahan
Pubblicazione: (2025)

NLRP7 engagement in transformation and etiology of chronic disease.
di: Mamoor, Shahan
Pubblicazione: (2025)

The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: TGFBI.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MTF1.
di: Mamoor, Shahan
Pubblicazione: (2025)

Xist is activated during resistance in triple negative breast cancer in vitro.
di: Mamoor, Shahan
Pubblicazione: (2025)

Importin 8 is activated in childhood brain cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: MAT1A.
di: Mamoor, Shahan
Pubblicazione: (2025)

Telomerase control of Xist through Trf2.
di: Mamoor, Shahan
Pubblicazione: (2025)

Phosphatase targeting in Luminal B breast cancer: PGP.
di: Mamoor, Shahan
Pubblicazione: (2025)

Matrix metalloproteinases MMP1/MMP9 function in melanoma resistance.
di: Mamoor, Shahan
Pubblicazione: (2025)

Phosphatase targeting in Luminal B breast cancer: PNKP.
di: Mamoor, Shahan
Pubblicazione: (2025)

Clec2b and Clec11a, co-receptors for KIR2DL3 natural killer cell self discrimination complexes, are altered in expression in the cells of patients with IBD.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: SRC.
di: Mamoor, Shahan
Pubblicazione: (2025)

ABC transporter multi-drug resistance genes ("pumps") in humans with non-small cell lung cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

HSC, CMP and CLP in mice.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MYO9B.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: NFATC1.
di: Mamoor, Shahan
Pubblicazione: (2025)

Aire is a component gene of the Th17 gene signature.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: GDF5.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: INPP5F.
di: Mamoor, Shahan
Pubblicazione: (2025)

A comprehensive description of the circulating tumor cell: TM6SF1.
di: Mamoor, Shahan
Pubblicazione: (2025)

FCGRT functions in senescence and transformation.
di: Mamoor, Shahan
Pubblicazione: (2025)

Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of liver metastasis: ACSM2B.
di: Mamoor, Shahan
Pubblicazione: (2025)

The genes encoded at the Dxz locus, DANT2/3, are components of an Xist gene expression regulation apparatus that utilizes quantitative control of message quantity of specific genes to measure and maintain transcription, globally, within homeostatic range.
di: Mamoor, Shahan
Pubblicazione: (2025)

Leukotriene activation in the blood of humans with high CRP.
di: Mamoor, Shahan
Pubblicazione: (2025)

TSC22D4 gene activation in Crohn's Disease.
di: Mamoor, Shahan
Pubblicazione: (2025)